The Second Annual Asheville Hematologic Malignancies Symposium

USF Health and i3 Health are pleased to announce the 2nd Annual Hematologic Malignancies Symposium. This unique CME/CE-certified 1-day event will bring together leading oncology investigators to review the latest treatment advances in hematologic malignancies and to discuss and debate clinical care issues that affect your everyday practice. All healthcare professionals involved in the treatment of hematologic malignancies are invited to attend.

The target audience for this conference is basically for Oncologists, hematologists, nurses, and other health care professionals involved in the treatment of patients with hematologic malignancies.

LEARNING OBJECTIVES

Upon completion of this activity, participants should be able to:

- Assess predictive and prognostic markers that affect treatment selection for patients with hematologic malignancies
- Differentiate current and emerging efficacy and safety data on novel therapies for hematologic malignancies
- Evaluate supportive care plans for patients with hematologic malignancies
- Apply recent advances to meet the needs of individual patients with hematologic malignancies